Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 10Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Prostatic Diseases 1Osteosarcoma 1Neuroblastoma 1Melanoma 1Kidney Neoplasms 1Hepatoblastoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

X-Rays 6Phantoms, Imaging 6Filgrastim 6Cyclophosphamide 6Carboplatin 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Ifosfamide 5Temozolomide 4Nuclear Medicine Department, Hospital 4Gemcitabine 4Etoposide 4Granulocyte Colony-Stimulating Factor 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ixabepilone 2ivosidenib 2etoposide phosphate 2ensartinib 2cabozantinib 2belinostat 2Vincristine 2Vemurafenib 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Cryotherapy × Genitourinary × Clear all
NCT05302921 2025-01-01

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Children's National Research Institute

Phase 2 Completed
5 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Melanoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡